Risk Factors of Immune-Mediated Hepatotoxicity Induced by Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis
Immune checkpoint inhibitors (ICIs) significantly improve survival, while immune-mediated hepatotoxicity (IMH) has been reported. To evaluate the incidence and potential risk factors of IMH among cancer patients treated by ICIs, PubMed/Medline, Web of Science, Cochrane, and Embase were searched befo...
Saved in:
| Main Authors: | Ying Jiang, Ranyi Li, Xiaoyu Li, Ningping Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Current Oncology |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1718-7729/31/11/525 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hepatotoxicity induced by immune checkpoint inhibitors
by: Flaviu Muresan, et al.
Published: (2024-10-01) -
Acute hepatitis in a paediatric patient: immune-mediated drug-induced liver injury or albendazole-induced autoimmune hepatitis?
by: Nataša Dragutinović, et al.
Published: (2022-10-01) -
Unlocking the potential of immune checkpoint inhibitors in advanced cervical cancer: a meta-analysis and systematic review
by: Zheng-rui Li, et al.
Published: (2025-05-01) -
Combination of immune checkpoint inhibitors and anthracyclines as a potential first-line regimen for dedifferentiated liposarcoma: systematic review and meta-analysis
by: Zhuang Aobo, et al.
Published: (2025-04-01) -
Adverse reactions of immune checkpoint inhibitors
by: E. R. Zagidullina, et al.
Published: (2025-06-01)